Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
about
RASopathies: unraveling mechanisms with animal modelsNeurofibromin Loss of Function Drives Excessive Grooming in DrosophilaNeurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.Optimizing biologically targeted clinical trials for neurofibromatosis.Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neuronsSex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.Skeletal muscle and motor deficits in Neurofibromatosis Type 1.Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice.Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in DrosophilaModeling cognitive dysfunction in neurofibromatosis-1Response inhibition in Attention deficit disorder and neurofibromatosis type 1 - clinically similar, neurophysiologically different.Conflict processing in juvenile patients with neurofibromatosis type 1 (NF1) and healthy controls - Two pathways to success.Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions.Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.Human stem cell modeling in neurofibromatosis type 1 (NF1).Modulation of cAMP and ras signaling pathways improves distinct behavioral deficits in a zebrafish model of neurofibromatosis type 1.Early development of infants with neurofibromatosis type 1: a case series.Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior.Neurological comorbidity in children with neurofibromatosis type 1.Attention and Executive Disorders in Neurofibromatosis 1: Comparison Between NF1 With ADHD Symptomatology (NF1 + ADHD) and ADHD Per Se
P2860
Q26800379-549C1275-6A72-4D6B-9E24-A3C4AB4C6C86Q27347271-130E5A0C-AB4A-4F06-8FD7-A18D801E1818Q30394733-D5935ACE-003D-4F1F-88EB-9BFA4E6792FFQ30438898-B0C9D428-A9AF-4237-9AB2-497E0332E01CQ33743618-F0D29E4B-3E75-4633-B59B-B31D3D1145B0Q34231047-4CE6E178-D84C-47E2-A518-D5AB59D07E43Q34478793-E747EB52-BFA6-45FE-8B7F-0F3EF6C84E58Q34770412-87B411A8-0590-4C18-8B5F-0482039D4A72Q36008044-01EC809B-2DEC-43C6-A921-9D259F92AEDCQ36719177-0010B211-1CA5-424A-8209-9B2AB26C8B96Q36756183-D16A6A16-915D-4202-A167-277B59B934EDQ37682078-00504CB1-FE82-4834-B894-8E4E13910E0EQ37682749-840B4B14-6C4E-4754-84B6-20A860E16776Q38243763-5926C6F6-4130-4363-B381-C0EA6021DA2BQ38607455-0413C440-1D87-4F7E-ADD4-3DF57707000CQ38732807-C7679603-A981-4307-ABA2-A0C085C4E25CQ45264996-ABE83206-097D-4781-A0CB-AF0C4B7470ECQ47165441-2FAB26E9-AAFD-46F2-BBF1-216696639430Q50655894-5C88E338-88D3-462D-AF63-06CF833927F5Q52088500-E3125F4F-8E69-41FC-B7EB-A484C7F7B265Q57581441-33039C2D-DCCC-408E-9C1A-4397F7DE437F
P2860
Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
@ast
Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
@en
type
label
Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
@ast
Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
@en
prefLabel
Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
@ast
Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
@en
P2093
P2860
P356
P1433
P1476
Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
@en
P2093
Charles F Zorumski
David F Wozniak
David H Gutmann
Kazuhiro Tokuda
Kelly A Diggs-Andrews
Yukitoshi Izumi
P2860
P304
P356
10.1002/ANA.23793
P577
2012-12-07T00:00:00Z